Elena Vladimirovna Gosteva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elena Vladimirovna Gosteva has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Ol'Ga A. Osipova
Belgorod State National Research University
14 shared publications - Lyudmila V. Vasilieva
N. N. Burdenko Voronezh State Medical University
8 shared publications - Ruslan Nikolaevich Shepel
National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
6 shared publications - Yuri A. Lykov
Belgorod National Research University
5 shared publications - Анастасия Сергеевна Брижанева
Belgorod State National Research University
5 shared publications - N. I. Klyushnikov
Voronezh City Clinical Hospital of Emergency Medical Care № 8
4 shared publications
Latest Publications
- 20 October 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (9) , 84-90
Cognitive status in elderly patients with chronic cerebral ischemia treated with Mexidol
Objective. To evaluate the efficacy of sequential Mexidol therapy, administered intravenously and orally over 74 days as part of a comprehensive treatment regimen, on cognitive status in elderly patients with chronic cerebral ischemia (CCI) and cognitive impairments. Material and methods. AThis prospective open-label study included 90 elderly patients with CCI (mean age 81±3 years). The main group (MG, n=43) received standard therapy plus Mexidol, and the comparison group (CG, n=47) received standard therapy alone. Cognitive function was assessed using the Mini-Mental State Examination (MMSE), Stroop test, and Schulte test at baseline and after three months. Results. At baseline, the groups were comparable in sex, age, and clinical and cognitive status. After three months of therapy, the median MMSE score in the main group (MG) was 27 points, significantly higher than the 26 points observed in the comparison group (CG) (p0.05). Conclusions. Sequential administration of Mexidol as part of comprehensive therapy in elderly patients with chronic cerebral ischemia led to greater improvements in cognitive status, speed and efficiency of mental performance, cognitive control, and mental resilience than standard therapy alone. These findings indicate pro-cognitive and neuroprotective effects of Mexidol.
- 20 October 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (9) , 84-90
Cognitive status in elderly patients with chronic cerebral ischemia treated with Mexidol
Objective. To evaluate the efficacy of sequential Mexidol therapy, administered intravenously and orally over 74 days as part of a comprehensive treatment regimen, on cognitive status in elderly patients with chronic cerebral ischemia (CCI) and cognitive impairments. Material and methods. AThis prospective open-label study included 90 elderly patients with CCI (mean age 81±3 years). The main group (MG, n=43) received standard therapy plus Mexidol, and the comparison group (CG, n=47) received standard therapy alone. Cognitive function was assessed using the Mini-Mental State Examination (MMSE), Stroop test, and Schulte test at baseline and after three months. Results. At baseline, the groups were comparable in sex, age, and clinical and cognitive status. After three months of therapy, the median MMSE score in the main group (MG) was 27 points, significantly higher than the 26 points observed in the comparison group (CG) (p0.05). Conclusions. Sequential administration of Mexidol as part of comprehensive therapy in elderly patients with chronic cerebral ischemia led to greater improvements in cognitive status, speed and efficiency of mental performance, cognitive control, and mental resilience than standard therapy alone. These findings indicate pro-cognitive and neuroprotective effects of Mexidol.
- Open Access
- 4 May 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (2) , 29-40
THE ROLE OF BIOMARKERS AND sST2 IN THE DEVELOPMENT OF POSTINFARCTION CHF IN ELDERLY PATIENTS
Highlights Biomarkers associated with inflammation (hf-CRP, NLR, SIRI) and fibrosis (sST-2) are associated with chronic heart failure and are predictors of worsening heart failure. The results obtained in elderly patients confirm the expediency of measuring the level of soluble ST2 to assess the clinical course of CHF after a myocardial infarction without ST elevation. Unlike traditional biochemical markers of inflammation, the calculation of NLR and SIRI indices based on a general blood test requires less time, which contributes to their more active implementation in medical practice. Background . One of the leading causes of chronic heart failure (CHF) in elderly patients is a recent myocardial infarction. There is particular interest in inflammatory biomarkers – those detectable via a complete blood count – and soluble ST2 (sST2) as a marker of myocardial fibrosis and remodeling. However, their role in the development of CHF during the post‑infarction period in elderly patients has not been sufficiently studied. Aim . To conduct a comprehensive assessment over a six‑month prospective follow‑up period of potential relationships between inflammatory biomarkers (C‑reactive protein, NLR, MLR, SII, SIRI) and soluble ST2 (sST2). Additionally, the objective is to determine their diagnostic significance in chronic heart failure among elderly patients who have experienced a non‑ST‑segment elevation myocardial infarction (NSTEMI). Methods . The study included 176 elderly patients who had suffered a non‑ST‑segment elevation myocardial infarction (NSTEMI) six months prior. Inclusion criteria: age: 60–74 years; NSTEMI occurred six months earlier; CHF with moderately reduced left ventricular ejection fraction at the time of hospital discharge. Examination procedures included: echocardiography; blood tests (complete blood count, biochemical analysis, levels of NT‑proBNP, C‑reactive protein, and sST2); calculation of inflammatory indices from the complete blood count: NLR (neutrophil‑to‑lymphocyte ratio); MLR (monocyte‑to‑lymphocyte ratio); SII (systemic inflammation index); SIRI (systemic inflammatory response index). The sST2 level was determined using the ELISA method (The RayBio® Human IL‑1 R4/ST2 ELISA kit, USA) according to the manufacturer’s protocol. Statistical analysis was performed using StatTech v.4.9.5 (Russia). Results . The best prognostic indicators were demonstrated by: high‑sensitivity C‑reactive protein (hs‑CRP) (AUC = 0.848, p < 0.001); NLR index (AUC = 0.802, p < 0.001). This was followed by the SIRI index (AUC = 0.774, p < 0.001). Furthermore, a comparison of the two patient groups showed a significant association between elevated levels of sST2 and inflammatory markers and the development of CHF, depending on the left ventricular ejection fraction. Conclusion . In elderly patients with myocardial infarction without ST elevation and initially moderately low EF (41–49%), the level of sST-2 ≥ 31.00 ng/l 6 months after the infarction was significantly higher in the absence of restoration of myocardial contractility than with normalization of the ejection fraction. NLR and SIRI indexes have the highest discrimination ability. A comprehensive assessment of sST-2, NLR/SIRI, and clinical factors allows stratification of patients to enhance personalized therapy and control.
- 4 May 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (2) , 29-40
Open AccessTHE ROLE OF BIOMARKERS AND sST2 IN THE DEVELOPMENT OF POSTINFARCTION CHF IN ELDERLY PATIENTS
Highlights Biomarkers associated with inflammation (hf-CRP, NLR, SIRI) and fibrosis (sST-2) are associated with chronic heart failure and are predictors of worsening heart failure. The results obtained in elderly patients confirm the expediency of measuring the level of soluble ST2 to assess the clinical course of CHF after a myocardial infarction without ST elevation. Unlike traditional biochemical markers of inflammation, the calculation of NLR and SIRI indices based on a general blood test requires less time, which contributes to their more active implementation in medical practice. Background . One of the leading causes of chronic heart failure (CHF) in elderly patients is a recent myocardial infarction. There is particular interest in inflammatory biomarkers – those detectable via a complete blood count – and soluble ST2 (sST2) as a marker of myocardial fibrosis and remodeling. However, their role in the development of CHF during the post‑infarction period in elderly patients has not been sufficiently studied. Aim . To conduct a comprehensive assessment over a six‑month prospective follow‑up period of potential relationships between inflammatory biomarkers (C‑reactive protein, NLR, MLR, SII, SIRI) and soluble ST2 (sST2). Additionally, the objective is to determine their diagnostic significance in chronic heart failure among elderly patients who have experienced a non‑ST‑segment elevation myocardial infarction (NSTEMI). Methods . The study included 176 elderly patients who had suffered a non‑ST‑segment elevation myocardial infarction (NSTEMI) six months prior. Inclusion criteria: age: 60–74 years; NSTEMI occurred six months earlier; CHF with moderately reduced left ventricular ejection fraction at the time of hospital discharge. Examination procedures included: echocardiography; blood tests (complete blood count, biochemical analysis, levels of NT‑proBNP, C‑reactive protein, and sST2); calculation of inflammatory indices from the complete blood count: NLR (neutrophil‑to‑lymphocyte ratio); MLR (monocyte‑to‑lymphocyte ratio); SII (systemic inflammation index); SIRI (systemic inflammatory response index). The sST2 level was determined using the ELISA method (The RayBio® Human IL‑1 R4/ST2 ELISA kit, USA) according to the manufacturer’s protocol. Statistical analysis was performed using StatTech v.4.9.5 (Russia). Results . The best prognostic indicators were demonstrated by: high‑sensitivity C‑reactive protein (hs‑CRP) (AUC = 0.848, p < 0.001); NLR index (AUC = 0.802, p < 0.001). This was followed by the SIRI index (AUC = 0.774, p < 0.001). Furthermore, a comparison of the two patient groups showed a significant association between elevated levels of sST2 and inflammatory markers and the development of CHF, depending on the left ventricular ejection fraction. Conclusion . In elderly patients with myocardial infarction without ST elevation and initially moderately low EF (41–49%), the level of sST-2 ≥ 31.00 ng/l 6 months after the infarction was significantly higher in the absence of restoration of myocardial contractility than with normalization of the ejection fraction. NLR and SIRI indexes have the highest discrimination ability. A comprehensive assessment of sST-2, NLR/SIRI, and clinical factors allows stratification of patients to enhance personalized therapy and control.
- 16 April 2026
- Published by ECO-Vector LLC (Publications) in Medical and Social Expert Evaluation and Rehabilitation
- Vol. 29 (1) , 5-14
Clinical study of the association of metabolic syndrome and obstructive sleep apnea in older patients
BACKGROUND: The relevance of the topic stems from the high comorbidity of metabolic syndrome and obstructive sleep apnea (OSA) in the older population, which increases the risk of cardiovascular complications and leads to the formation of a vicious circle. AIM: To study the interrelationship between the components of metabolic syndrome and moderate obstructive sleep apnea in older patients. METHODS: The study included 132 older patients (67.1 ± 2.9 years). Depending on the presence of abdominal obesity (AO) and OSA, four groups were formed: group 1, AO−/OSA− (32 participants); group 2, AO−/OSA+ (30 participants); group 3, AO+/OSA− (34 participants); and group 4, AO+/OSA+ (36 participants). RESULTS: The most pronounced worsening of the metabolic profile was observed in older patients with comorbidity of AO and OSA: progression of insulin resistance (by HOMA-IR), deterioration of integral metabolic status (pronounced increase in TyG), and enhancement of the atherogenic dyslipidemic profile (increased triglycerides / low-density lipoprotein cholesterol). The highest blood pressure values and the greatest prevalence of circadian rhythm disturbances were found in AO+/OSA+ patients, indicating a more severe course of hypertension in this group compared with the others. Correlation analysis confirmed the high diagnostic efficacy of the TyG index as a marker of metabolic disorders in elderly patients (ρ = 0.847, p 0.001). CONCLUSION: The presented data suggest that the highest risk of metabolic disorders and the most severe course of arterial hypertension were observed in patients with comorbidity of abdominal obesity and moderate obstructive sleep apnea. The TyG index has high diagnostic accuracy for metabolic disorders in older patients.
- 16 April 2026
- Published by ECO-Vector LLC (Publications) in Medical and Social Expert Evaluation and Rehabilitation
- Vol. 29 (1) , 5-14
Clinical study of the association of metabolic syndrome and obstructive sleep apnea in older patients
BACKGROUND: The relevance of the topic stems from the high comorbidity of metabolic syndrome and obstructive sleep apnea (OSA) in the older population, which increases the risk of cardiovascular complications and leads to the formation of a vicious circle. AIM: To study the interrelationship between the components of metabolic syndrome and moderate obstructive sleep apnea in older patients. METHODS: The study included 132 older patients (67.1 ± 2.9 years). Depending on the presence of abdominal obesity (AO) and OSA, four groups were formed: group 1, AO−/OSA− (32 participants); group 2, AO−/OSA+ (30 participants); group 3, AO+/OSA− (34 participants); and group 4, AO+/OSA+ (36 participants). RESULTS: The most pronounced worsening of the metabolic profile was observed in older patients with comorbidity of AO and OSA: progression of insulin resistance (by HOMA-IR), deterioration of integral metabolic status (pronounced increase in TyG), and enhancement of the atherogenic dyslipidemic profile (increased triglycerides / low-density lipoprotein cholesterol). The highest blood pressure values and the greatest prevalence of circadian rhythm disturbances were found in AO+/OSA+ patients, indicating a more severe course of hypertension in this group compared with the others. Correlation analysis confirmed the high diagnostic efficacy of the TyG index as a marker of metabolic disorders in elderly patients (ρ = 0.847, p 0.001). CONCLUSION: The presented data suggest that the highest risk of metabolic disorders and the most severe course of arterial hypertension were observed in patients with comorbidity of abdominal obesity and moderate obstructive sleep apnea. The TyG index has high diagnostic accuracy for metabolic disorders in older patients.
- Open Access
- 22 March 2026
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 104 (1) , 44-51
The Impact of Sarcopenic Obesity on the Course of Chronic Obstructive Pulmonary Disease in Elderly Men
The objective: to study the potential effect of sarcopenic obesity (SO) on the course of chronic obstructive pulmonary disease (COPD) in elderly men. Subjects and Methods. Seventy-four men aged 60-74 years were examined. All of them had COPD GOLD II, Group A or B, and a post-bronchodilator FEV1/FVC ratio Results. Patients with COPD+SO versus COPD Group were older ( p =0.047), had more pronounced inflammaging according to the neutrophil/lymphocyte ratio (NLR), monocyte/lymphocyte ratio (MLR), and systemic inflammatory index. When assessing relationship between MLR and percentage of body fat (PBF), a direct relationship was established ( p =0.842, p p =0.010), and the chance of moderate dyspnea (mMRS=2) was 9.7 times higher. The impact of COPD on the quality of life of patients (according to SAT test) was 8.4 times higher when combined with SO. Patients with mild dyspnea (0-1 as per) had significantly higher muscle mass values than those with moderate or severe dyspnea, regardless of their SO status ( p =0.04). Patients with COPD+SO had more pronounced impairments of their physical activity according to the 6MW and 5.squat-stand tests ( p <0.001).
- 22 March 2026
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 104 (1) , 44-51
Open AccessThe Impact of Sarcopenic Obesity on the Course of Chronic Obstructive Pulmonary Disease in Elderly Men
The objective: to study the potential effect of sarcopenic obesity (SO) on the course of chronic obstructive pulmonary disease (COPD) in elderly men. Subjects and Methods. Seventy-four men aged 60-74 years were examined. All of them had COPD GOLD II, Group A or B, and a post-bronchodilator FEV1/FVC ratio Results. Patients with COPD+SO versus COPD Group were older ( p =0.047), had more pronounced inflammaging according to the neutrophil/lymphocyte ratio (NLR), monocyte/lymphocyte ratio (MLR), and systemic inflammatory index. When assessing relationship between MLR and percentage of body fat (PBF), a direct relationship was established ( p =0.842, p p =0.010), and the chance of moderate dyspnea (mMRS=2) was 9.7 times higher. The impact of COPD on the quality of life of patients (according to SAT test) was 8.4 times higher when combined with SO. Patients with mild dyspnea (0-1 as per) had significantly higher muscle mass values than those with moderate or severe dyspnea, regardless of their SO status ( p =0.04). Patients with COPD+SO had more pronounced impairments of their physical activity according to the 6MW and 5.squat-stand tests ( p <0.001).
- Open Access
- 20 October 2025
- Published by Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology in Russian Journal of Geriatric Medicine
- No. 3,p. 431-433
Association of sarcopenia with systemic immune inflammatory index in elderly patients
The relationship between the immune inflammatory index (SII) and sarcopenia in older patients, specifically in terms of muscle mass and relative strength, was assessed. The SII has shown promising predictive ability and high efficacy in identifying decreased muscle function among older individuals.BACKGROUND. In elderly people, sarcopenia can lead to a decrease in functional activity and the ability to perform self-care activities, as well as an increased risk of falling. A general blood test is a common laboratory test that can be used to measure various components that can act as markers for inflammation. The SII index, which is calculated by multiplying the number of platelets by neutrophils and dividing by lymphocytes, is more accurate than C-reactive protein in predicting coronary heart disease. It can also effectively predict the development and progression of heart failure. However, the relationship between sarcopenia and the SII index has not yet been fully investigated.THE OBJECTIVE OF THE STUDY ― to investigate the relationship between the inflammatory index SII (platelet-neutrophil ratio/lymphocyte count) and muscle mass and strength.MATERIALS AND METHODS. The study included 65 elderly men with an average age of 70.4 ± 3.2 year. Sarcopenia was diagnosed using the EWGSOP criteria. The participants were divided into two groups: group 1 included 32 men with sarcopenia, and group 2 included 33 men without sarcopenia. The inclusion criteria were: the age of the patients was 60–74 years, and all stages of the study had been completed.Muscle mass index (MMI) was determined by dividing muscle mass by body mass index (BMI). For men, an MMI below 0.789 was considered low. Grip strength was measured by squeezing a dynamometer in each hand 3 times for 5 seconds, and the average value was taken. The elbow was positioned at a right angle to the body. Relative Strength Index (RSI) was calculated by dividing dominant arm muscle strength by BMI.Statistical analysis was performed using ROC analysis to evaluate MMI in predicting low muscle mass and strength risk. Spearman's correlation analysis was used to assess the relationship between SII, MMI, and muscle strength.RESULTS. Patients with sarcopenia had a significantly higher BMI (p < 0.001, mean (32.03 ± 6.28) kg/m²) compared to those without sarcopenia (mean (25.98 ± 5.03) kg/m²). They also had lower BMI (mean 0.68 ± 0.09 vs 0.87 ± 0.06) and BMI (1.12 ± 0.17 vs 1.52 ± 0.23). An increase in BMI was associated with a decrease in RSI.Patients without sarcopenia had lower platelet and lymphocyte counts. The SII value was significantly higher in patients with sarcopenia (548.36 ± 232.63) compared to those without (414.42 ± 205.25, pCONCLUSION. The SII index has demonstrated reliable predictive ability and high efficiency in detecting decreased muscle function in elderly patients.
- 20 October 2025
- Published by Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology in Russian Journal of Geriatric Medicine
- No. 3,p. 431-433
Open AccessAssociation of sarcopenia with systemic immune inflammatory index in elderly patients
The relationship between the immune inflammatory index (SII) and sarcopenia in older patients, specifically in terms of muscle mass and relative strength, was assessed. The SII has shown promising predictive ability and high efficacy in identifying decreased muscle function among older individuals.BACKGROUND. In elderly people, sarcopenia can lead to a decrease in functional activity and the ability to perform self-care activities, as well as an increased risk of falling. A general blood test is a common laboratory test that can be used to measure various components that can act as markers for inflammation. The SII index, which is calculated by multiplying the number of platelets by neutrophils and dividing by lymphocytes, is more accurate than C-reactive protein in predicting coronary heart disease. It can also effectively predict the development and progression of heart failure. However, the relationship between sarcopenia and the SII index has not yet been fully investigated.THE OBJECTIVE OF THE STUDY ― to investigate the relationship between the inflammatory index SII (platelet-neutrophil ratio/lymphocyte count) and muscle mass and strength.MATERIALS AND METHODS. The study included 65 elderly men with an average age of 70.4 ± 3.2 year. Sarcopenia was diagnosed using the EWGSOP criteria. The participants were divided into two groups: group 1 included 32 men with sarcopenia, and group 2 included 33 men without sarcopenia. The inclusion criteria were: the age of the patients was 60–74 years, and all stages of the study had been completed.Muscle mass index (MMI) was determined by dividing muscle mass by body mass index (BMI). For men, an MMI below 0.789 was considered low. Grip strength was measured by squeezing a dynamometer in each hand 3 times for 5 seconds, and the average value was taken. The elbow was positioned at a right angle to the body. Relative Strength Index (RSI) was calculated by dividing dominant arm muscle strength by BMI.Statistical analysis was performed using ROC analysis to evaluate MMI in predicting low muscle mass and strength risk. Spearman's correlation analysis was used to assess the relationship between SII, MMI, and muscle strength.RESULTS. Patients with sarcopenia had a significantly higher BMI (p < 0.001, mean (32.03 ± 6.28) kg/m²) compared to those without sarcopenia (mean (25.98 ± 5.03) kg/m²). They also had lower BMI (mean 0.68 ± 0.09 vs 0.87 ± 0.06) and BMI (1.12 ± 0.17 vs 1.52 ± 0.23). An increase in BMI was associated with a decrease in RSI.Patients without sarcopenia had lower platelet and lymphocyte counts. The SII value was significantly higher in patients with sarcopenia (548.36 ± 232.63) compared to those without (414.42 ± 205.25, pCONCLUSION. The SII index has demonstrated reliable predictive ability and high efficiency in detecting decreased muscle function in elderly patients.
- Open Access
- 10 September 2024
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in University therapeutic journal
- Vol. 6 (3) , 116-124
ОЦЕНКА БИОМАРКЕРОВ СИСТЕМНОГО ВОСПАЛЕНИЯ У ЖЕНЩИН ПОЖИЛОГО ВОЗРАСТА С ОСТЕОАРТРИТОМ КОЛЕННОГО СУСТАВА
Остеоартрит (ОА) — хроническое заболевание, ассоциированное с возрастом, полом, метаболическими нарушениями, генетическими и биохимическими факторами, характеризующееся разрушением суставов, гиперплазией костей и дегенерацией суставного хряща, обусловленное воспалительными патогенетическими механизмами. Гематологические индексы клеточной реактивности (соотношение количества лимфоцитов, нейтрофилов, моноцитов и тромбоцитов) значительно изменяются во время системного воспаления, что обосновывает интерес к их изучению при остеоартрите коленного сустава (ОАКС). Однако эти индексы не изучены у женщин пожилого возраста при различной степени тяжести ОАКС. Цель исследования — сравнение уровней маркеров системного воспаления в зависимости от степени тяжести ОАКС (по Келлгрену и Лоуренсу) у женщин пожилого возраста. Материалы и методы. В исследование были включены 86 женщин с ОАКС в возрасте 69±3 года. Результаты. У пациентов с III степенью ОАКС в крови выявлены более высокие уровни моноцитов (18,6%, р <0,01), индексов NLR (соотношение количества нейтрофилов/лимфоцитов) (15,6%, р <0,05), MLR (соотношение количества моноцитов/лимфоцитов) (29,6%, р <0,01), PLR (соотношение количества тромбоцитов/лимфоцитов) (12,6%, р <0,05), СОЭ (26,7%, р <0,01), СРБ (С-реактивный белок) (24,5%, р <0,01), МСР-1 (моноцитарный хемотаксический протеин-1) (20,2%, р <0,01) и более низкие значения лимфоцитов (11,1%, р <0,05), чем с I–II степенью тяжести. Корреляционный анализ показал наличие положительной связи СОЭ с уровнем NLR (r=0,215, р=0,021), MLR (r=0,223, р=0,017), РLR (r=0,199, р=0,033), СРБ с NLR (r=0,223, р=0,017), MLR (r=0,328, р<0,001), РLR (r=0,190, р=0,042), МСР-1 с MLR (r=0,213, р=0,022). Выводы. Высокая положительная корреляционная взаимосвязь между MLR, NLR, PLR, и СОЭ, СРБ, МСР-1 и отсутствие корреляции с возрастом указывает на то, что MLR и NLR в сочетании с СОЭ и СРБ, МСР-1 могут являться предикторами степени тяжести ОАКС. Osteoarthritis (OA) is a chronic disease associated with age, gender, metabolicdisorders, genetic and biochemical factors, characterized by joint destruction, bone hyperplasia anddegeneration of articular cartilage due to inflammatory pathogenetic mechanisms. Hematologicalindices of cellular reactivity (the ratio of the number of lymphocytes, neutrophils, monocytes andplatelets) change significantly during systemic inflammation, which justifies the interest in theirstudy in osteoarthritis of the knee joint (OAK). However, these indices have not been studied in elderly women with varying degrees of severity of OAK. The aim of the study was to compare the levels of markers of systemic inflammation depending on the severity of OAK (according to Kellgren and Lawrence) in elderly women. Materials and methods. The study included 86 women with OAK at the age of 69±3 years. Results. Atients with grade III ОAC have been identified higher levels of monocytes (18.6%, p <0.01), NLR (neutrophil/lymphocyte ratio) indices (15.6%, p <0.05), MLR (monocyte/lymphocyte ratio) (29.6%, p <0.01), PLR (platelet/lymphocyte ratio) (12.6%, p <0.05), BSR (26.7%, p <0.01), CRP (C-reactive protein) (24.5%, p <0.01), MCP-1 (monocyte chemotactic protein-1) (20.2%, p <0.01) and lower lymphocyte values (11.1%, p <0.05) than with I–II degrees of severity. Correlation analysis showed the presence of a positive association of BSR with the level of NLR (r=0.215, p=0.021), MLR (r=0.223, p=0.017), PLR (r=0.1199, p=0.033), CRP with NLR (r=0.223, p=0.017), MLR (r=0.328, p <0.001), PLR (r=0.190, p=0.042), MCP-1 with MLR (r=0.213, p=0.022). Conclusions. The high positive correlation between MLR, NLR, PLR, and BSR, CRP, MCP-1 and the absence of correlation with age indicates that MLR and NLR in combination with BSR and CRP, MCP-1 may be predictors of the severity of OAK.
- 10 September 2024
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in University therapeutic journal
- Vol. 6 (3) , 116-124
Open AccessОЦЕНКА БИОМАРКЕРОВ СИСТЕМНОГО ВОСПАЛЕНИЯ У ЖЕНЩИН ПОЖИЛОГО ВОЗРАСТА С ОСТЕОАРТРИТОМ КОЛЕННОГО СУСТАВА
Остеоартрит (ОА) — хроническое заболевание, ассоциированное с возрастом, полом, метаболическими нарушениями, генетическими и биохимическими факторами, характеризующееся разрушением суставов, гиперплазией костей и дегенерацией суставного хряща, обусловленное воспалительными патогенетическими механизмами. Гематологические индексы клеточной реактивности (соотношение количества лимфоцитов, нейтрофилов, моноцитов и тромбоцитов) значительно изменяются во время системного воспаления, что обосновывает интерес к их изучению при остеоартрите коленного сустава (ОАКС). Однако эти индексы не изучены у женщин пожилого возраста при различной степени тяжести ОАКС. Цель исследования — сравнение уровней маркеров системного воспаления в зависимости от степени тяжести ОАКС (по Келлгрену и Лоуренсу) у женщин пожилого возраста. Материалы и методы. В исследование были включены 86 женщин с ОАКС в возрасте 69±3 года. Результаты. У пациентов с III степенью ОАКС в крови выявлены более высокие уровни моноцитов (18,6%, р <0,01), индексов NLR (соотношение количества нейтрофилов/лимфоцитов) (15,6%, р <0,05), MLR (соотношение количества моноцитов/лимфоцитов) (29,6%, р <0,01), PLR (соотношение количества тромбоцитов/лимфоцитов) (12,6%, р <0,05), СОЭ (26,7%, р <0,01), СРБ (С-реактивный белок) (24,5%, р <0,01), МСР-1 (моноцитарный хемотаксический протеин-1) (20,2%, р <0,01) и более низкие значения лимфоцитов (11,1%, р <0,05), чем с I–II степенью тяжести. Корреляционный анализ показал наличие положительной связи СОЭ с уровнем NLR (r=0,215, р=0,021), MLR (r=0,223, р=0,017), РLR (r=0,199, р=0,033), СРБ с NLR (r=0,223, р=0,017), MLR (r=0,328, р<0,001), РLR (r=0,190, р=0,042), МСР-1 с MLR (r=0,213, р=0,022). Выводы. Высокая положительная корреляционная взаимосвязь между MLR, NLR, PLR, и СОЭ, СРБ, МСР-1 и отсутствие корреляции с возрастом указывает на то, что MLR и NLR в сочетании с СОЭ и СРБ, МСР-1 могут являться предикторами степени тяжести ОАКС. Osteoarthritis (OA) is a chronic disease associated with age, gender, metabolicdisorders, genetic and biochemical factors, characterized by joint destruction, bone hyperplasia anddegeneration of articular cartilage due to inflammatory pathogenetic mechanisms. Hematologicalindices of cellular reactivity (the ratio of the number of lymphocytes, neutrophils, monocytes andplatelets) change significantly during systemic inflammation, which justifies the interest in theirstudy in osteoarthritis of the knee joint (OAK). However, these indices have not been studied in elderly women with varying degrees of severity of OAK. The aim of the study was to compare the levels of markers of systemic inflammation depending on the severity of OAK (according to Kellgren and Lawrence) in elderly women. Materials and methods. The study included 86 women with OAK at the age of 69±3 years. Results. Atients with grade III ОAC have been identified higher levels of monocytes (18.6%, p <0.01), NLR (neutrophil/lymphocyte ratio) indices (15.6%, p <0.05), MLR (monocyte/lymphocyte ratio) (29.6%, p <0.01), PLR (platelet/lymphocyte ratio) (12.6%, p <0.05), BSR (26.7%, p <0.01), CRP (C-reactive protein) (24.5%, p <0.01), MCP-1 (monocyte chemotactic protein-1) (20.2%, p <0.01) and lower lymphocyte values (11.1%, p <0.05) than with I–II degrees of severity. Correlation analysis showed the presence of a positive association of BSR with the level of NLR (r=0.215, p=0.021), MLR (r=0.223, p=0.017), PLR (r=0.1199, p=0.033), CRP with NLR (r=0.223, p=0.017), MLR (r=0.328, p <0.001), PLR (r=0.190, p=0.042), MCP-1 with MLR (r=0.213, p=0.022). Conclusions. The high positive correlation between MLR, NLR, PLR, and BSR, CRP, MCP-1 and the absence of correlation with age indicates that MLR and NLR in combination with BSR and CRP, MCP-1 may be predictors of the severity of OAK.
- 19 June 2024
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 23 (8)
Factors associated with deterioration of myocardial inotropic function in patients with coronary artery disease
Material and methods. One hundred patients with functional class III-IV CAD, stage I-IIa heart failure with LV ejection fraction (EF) >40%, successful coronary artery bypass grafting, SYNTAX Score of 33. During hospitalization, echocardiography, matrix metalloproteinase 9 (MMP-9), tissue inhibitor of metalloproteinase 1 (TIMP-1), monocyte chemoattractant protein 1 (MCP-1) were studied, while systemic immune-inflammation index (SII) was estimated. After 6 months, echocardiography revealed a group of patients with a decrease in LVEF. Results. The following factors of decreased LVEF were identified: type 2 diabetes, chronic kidney disease (p4 comorbid diseases (r=-0,597, p<0,001), increase in SII by 44,6% (p<0,001), MMP-9 by 62% (p<0,001), MCP-1 by 55,1% (p<0,001), TIMP-1 by 45,8% (p<0,001). An inverse relationship was found between LVEF and the level of SII (r=-0,626, p<0,001), MCP-1 (r=-0,747, p<0,001), MMP-9 (r=-0,718, p4 comorbid diseases, SII, MMP-9 and MCP-1 with a threshold value of 356,43, 318,7 ng/ml and 459,6 pg/ml, respectively.
- 19 June 2024
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 23 (8)
Factors associated with deterioration of myocardial inotropic function in patients with coronary artery disease
Material and methods. One hundred patients with functional class III-IV CAD, stage I-IIa heart failure with LV ejection fraction (EF) >40%, successful coronary artery bypass grafting, SYNTAX Score of 33. During hospitalization, echocardiography, matrix metalloproteinase 9 (MMP-9), tissue inhibitor of metalloproteinase 1 (TIMP-1), monocyte chemoattractant protein 1 (MCP-1) were studied, while systemic immune-inflammation index (SII) was estimated. After 6 months, echocardiography revealed a group of patients with a decrease in LVEF. Results. The following factors of decreased LVEF were identified: type 2 diabetes, chronic kidney disease (p4 comorbid diseases (r=-0,597, p<0,001), increase in SII by 44,6% (p<0,001), MMP-9 by 62% (p<0,001), MCP-1 by 55,1% (p<0,001), TIMP-1 by 45,8% (p<0,001). An inverse relationship was found between LVEF and the level of SII (r=-0,626, p<0,001), MCP-1 (r=-0,747, p<0,001), MMP-9 (r=-0,718, p4 comorbid diseases, SII, MMP-9 and MCP-1 with a threshold value of 356,43, 318,7 ng/ml and 459,6 pg/ml, respectively.
- Open Access
- 19 June 2024
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 23 (8) , 4081
Factors associated with deterioration of myocardial inotropic function in patients with coronary artery disease
Material and methods. One hundred patients with functional class III-IV CAD, stage I-IIa heart failure with LV ejection fraction (EF) >40%, successful coronary artery bypass grafting, SYNTAX Score of 33. During hospitalization, echocardiography, matrix metalloproteinase 9 (MMP-9), tissue inhibitor of metalloproteinase 1 (TIMP-1), monocyte chemoattractant protein 1 (MCP-1) were studied, while systemic immune-inflammation index (SII) was estimated. After 6 months, echocardiography revealed a group of patients with a decrease in LVEF.Results. The following factors of decreased LVEF were identified: type 2 diabetes, chronic kidney disease (p4 comorbid diseases (r=-0,597, p<0,001), increase in SII by 44,6% (p<0,001), MMP-9 by 62% (p<0,001), MCP-1 by 55,1% (p<0,001), TIMP-1 by 45,8% (p<0,001). An inverse relationship was found between LVEF and the level of SII (r=-0,626, p<0,001), MCP-1 (r=-0,747, p<0,001), MMP-9 (r=-0,718, p4 comorbid diseases, SII, MMP-9 and MCP-1 with a threshold value of 356,43, 318,7 ng/ml and 459,6 pg/ml, respectively.
- 19 June 2024
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 23 (8) , 4081
Open AccessFactors associated with deterioration of myocardial inotropic function in patients with coronary artery disease
Material and methods. One hundred patients with functional class III-IV CAD, stage I-IIa heart failure with LV ejection fraction (EF) >40%, successful coronary artery bypass grafting, SYNTAX Score of 33. During hospitalization, echocardiography, matrix metalloproteinase 9 (MMP-9), tissue inhibitor of metalloproteinase 1 (TIMP-1), monocyte chemoattractant protein 1 (MCP-1) were studied, while systemic immune-inflammation index (SII) was estimated. After 6 months, echocardiography revealed a group of patients with a decrease in LVEF.Results. The following factors of decreased LVEF were identified: type 2 diabetes, chronic kidney disease (p4 comorbid diseases (r=-0,597, p<0,001), increase in SII by 44,6% (p<0,001), MMP-9 by 62% (p<0,001), MCP-1 by 55,1% (p<0,001), TIMP-1 by 45,8% (p<0,001). An inverse relationship was found between LVEF and the level of SII (r=-0,626, p<0,001), MCP-1 (r=-0,747, p<0,001), MMP-9 (r=-0,718, p4 comorbid diseases, SII, MMP-9 and MCP-1 with a threshold value of 356,43, 318,7 ng/ml and 459,6 pg/ml, respectively.
- Open Access
- 15 December 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (12) , 3819
Role of biomarkers of collagen metabolism and systemic inflammation in myocardial remodeling in patients with stable chronic coronary artery disease and obstructive sleep apnea
Aim. To study the relationship of biomarkers of collagen metabolism and systemic inflammation with left ventricular (LV) remodeling in patients with stable coronary artery disease (CAD) and obstructive sleep apnea (OSA). Material and methods . The study included 195 patients with stable CAD, of which 63 without OSA and 132 patients with combination of CAD and OSA. The mean age of patients was 63,4±3,7 years. Biomarkers of collagen metabolism and systemic inflammation were assessed by determining the concentration of matrix metalloproteinase (MMP)-9, tissue inhibitor of matrix metalloproteinase-1, monocyte chemoattractant protein-1 (MCP-1) and calculating the neutrophil-to-lymphocyte (NLR) and platelet-tolymphocyte ratio (PLR). Echocardiography was performed according to a standard protocol. Results. There were no significant differences in systemic inflammation parameters (MCP-1, NLR, PLR) between the group of patients with CAD and CAD with mild OSA and a significantly higher level of MCP-1, NLR, PLR in more severe OSA. In patients with CAD and severe OSA, the eccentric LV remodeling was diagnosed in 75% of individuals, while the concentric type was diagnosed in only 25%. Conclusion. In patients with stable CAD, the more severe the OSA, the more pronounced systemic inflammation (MCP-1, NLR, PLR), and there are higher proportion of eccentric LV hypertrophy, which may be associated with an imbalance of fibrosis markers (high concentration of MMP-9 with an almost unchanged level of tissue inhibitor of MMP-1).
- 15 December 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (12) , 3819
Open AccessRole of biomarkers of collagen metabolism and systemic inflammation in myocardial remodeling in patients with stable chronic coronary artery disease and obstructive sleep apnea
Aim. To study the relationship of biomarkers of collagen metabolism and systemic inflammation with left ventricular (LV) remodeling in patients with stable coronary artery disease (CAD) and obstructive sleep apnea (OSA). Material and methods . The study included 195 patients with stable CAD, of which 63 without OSA and 132 patients with combination of CAD and OSA. The mean age of patients was 63,4±3,7 years. Biomarkers of collagen metabolism and systemic inflammation were assessed by determining the concentration of matrix metalloproteinase (MMP)-9, tissue inhibitor of matrix metalloproteinase-1, monocyte chemoattractant protein-1 (MCP-1) and calculating the neutrophil-to-lymphocyte (NLR) and platelet-tolymphocyte ratio (PLR). Echocardiography was performed according to a standard protocol. Results. There were no significant differences in systemic inflammation parameters (MCP-1, NLR, PLR) between the group of patients with CAD and CAD with mild OSA and a significantly higher level of MCP-1, NLR, PLR in more severe OSA. In patients with CAD and severe OSA, the eccentric LV remodeling was diagnosed in 75% of individuals, while the concentric type was diagnosed in only 25%. Conclusion. In patients with stable CAD, the more severe the OSA, the more pronounced systemic inflammation (MCP-1, NLR, PLR), and there are higher proportion of eccentric LV hypertrophy, which may be associated with an imbalance of fibrosis markers (high concentration of MMP-9 with an almost unchanged level of tissue inhibitor of MMP-1).
- Open Access
- 26 September 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (9) , 3705
24-hour blood pressure profile and systemic inflammation in patients with stable coronary artery disease with obstructive sleep apnea
Aim. To evaluate 24-hour blood pressure (BP) profile and systemic inflammation in patients with coronary artery disease (CAD) depending on the presence of obstructive sleep apnea (OSA). Material and methods. This cross-sectional cohort study included 132 patients with CAD aged 62,3±6,9 years. Depending on OSA, all patients were divided into 2 groups: group 1 (n=60) — without OSA, group 2 (n=72) — with OSA. Systemic inflammation was assessed using neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), monocyte/lymphocyte ratio (MLR), Systemic immune-inflammation index (SII) — platelets´neutrophils/lymphocytes. Blood pressure was monitored with assessment of average daily values, circadian rhythm, and variability. Results . Patients with OSA had higher nighttime blood pressure values (pConclusion. We established that patients with coronary artery disease and OSA have more pronounced systemic inflammation, more often have a pathological 24-hour BP profile ("non-dipper", "night-peaker"), BP variability, higher values of average 24-hour, daytime and nighttime BP compared with patients without OSA.
- 26 September 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (9) , 3705
Open Access24-hour blood pressure profile and systemic inflammation in patients with stable coronary artery disease with obstructive sleep apnea
Aim. To evaluate 24-hour blood pressure (BP) profile and systemic inflammation in patients with coronary artery disease (CAD) depending on the presence of obstructive sleep apnea (OSA). Material and methods. This cross-sectional cohort study included 132 patients with CAD aged 62,3±6,9 years. Depending on OSA, all patients were divided into 2 groups: group 1 (n=60) — without OSA, group 2 (n=72) — with OSA. Systemic inflammation was assessed using neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), monocyte/lymphocyte ratio (MLR), Systemic immune-inflammation index (SII) — platelets´neutrophils/lymphocytes. Blood pressure was monitored with assessment of average daily values, circadian rhythm, and variability. Results . Patients with OSA had higher nighttime blood pressure values (pConclusion. We established that patients with coronary artery disease and OSA have more pronounced systemic inflammation, more often have a pathological 24-hour BP profile ("non-dipper", "night-peaker"), BP variability, higher values of average 24-hour, daytime and nighttime BP compared with patients without OSA.